DEA
LH icon

DoubleLine ETF Adviser’s Labcorp LH Stock Holding History

DoubleLine ETF Adviser’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Sell
1,169
-74
-6% -$19.5K 0.14% 141
2026
Q1 		$332K Buy
+1,243
New +$337K 0.13% 143

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DoubleLine ETF Adviser's LH Position: Q2 2026 in Review

DoubleLine ETF Adviser reduced its Labcorp (LH) stake by 6% in Q2 2026, selling an estimated $19.5K and leaving 1,169 shares worth $327K. The position accounts for 0.14% of the portfolio, ranked #141.

DoubleLine ETF Adviser first reported a position in LH in Q1 2026 and has held it in 2 quarters since. The position peaked at $332K in Q1 2026. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • DoubleLine ETF Adviser held 1,169 shares of Labcorp worth $327K as of Q2 2026.
  • DoubleLine ETF Adviser sold 74 Labcorp shares in Q2 2026, an estimated $19.5K.
  • Labcorp made up 0.14% of DoubleLine ETF Adviser's portfolio in Q2 2026, its #141 holding.
  • DoubleLine ETF Adviser first reported a position in Labcorp in Q1 2026 and has held it in 2 quarters since.
  • DoubleLine ETF Adviser's Labcorp position peaked at $332K in Q1 2026.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.